Earn CME: https://naccme.com/program/19-gdugi-2 In this webcast from the ‘Making Progress in Advanced Hepatocellular Carcinoma with Targeted Agents: Considerations for Therapeutic Selection, Toxicity Management, and Sequencing’ symposium during the 2019 Great Debates & Updates in Gastrointestinal Malignancies conference, Dr. David H. Ilson provides an update on the current standard of care for gastric cancer in the first line setting. รยฉ 2019 Imedex, an HMP Company
Advertisement